CYP2E1 and head and neck cancer: Another meta-analysis of case-control studies on the association between CYP2E1 polymorphisms and head and neck cancer risk showed that individuals, especially Asians, homozygous for CYP2E1*5 -1293C had an increased risk for developing head and neck cancer [37].